Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Abstract Background The potential benefits and risks of combination therapy with sodium-glucose co-transporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus monotherapy remain a subject of debate to optimize metabolic and cardiovascular outcomes in patients with type 2 diabetes mellitus
Statistical Analysis All statistical analyses were conducted using the SPSS version 17.0 (SPSS, Chicago, Illinois, USA)
Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity
Avoid using alcohol while taking SSRIs, as it can worsen depression and drowsiness symptoms
Sample availability can also be inquired about prior to placing a full order
US$ 21.09
US$ 23.03
US$ 20.47
US$ 22.90
